TPO- receptorstimulatorer kan i teorien stimulere progression af eksisterende hæmatopoietiske maligniteter eller MDS.
For TPO receptor stimulators there is a theoretical concern that they may stimulate the progression of existing haematopoietic malignancies or MDS.